By dividing pharmaceutical company's research and development budgets by the number of approved drugs over 15 years, Forbes' Matthew Herper and Scott DeCarlo came up with new estimates of drug development costs. "The range of money spent is stunning," Herper says at his blog.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.